Typing of Staphylococcus aureus isolated from bovine mastitis cases in Australia and India

Australian Veterinary Journal

Volumn 93, Issue 8, 2015, Pages 278-282

  Gogoi Tiwari, J ^a   Babra Waryah, C ^a   Sunagar, R ^b   Veeresh, H B ^c   Nuthanalakshmi, V ^c   Preethirani, P L ^c   Sharada, R ^c   Isloor, S ^c   Bhat, A ^c   Al Salami, H ^a   Hegde, N R ^b   Mukkur, T K ^a  

^a CURTIN UNIVERSITY   (Australia)

^b Ella Foundation   (India)

^c VETERINARY COLLEGE   (India)

Author keywords

Capsular and polysaccharide antigen 336; Dairy cattle; Mastitis; Molecular typing; Serology

Indexed keywords

BOS; BOVINAE; STAPHYLOCOCCUS AUREUS;

BACTERIAL DNA; BACTERIAL POLYSACCHARIDE;

ANIMAL; AUSTRALIA; BACTERIAL CAPSULE; BOVINE; BOVINE MASTITIS; CLASSIFICATION; FEMALE; GENETICS; GENOTYPE; GENOTYPING TECHNIQUE; GERMFREE ANIMAL; INDIA; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOUSE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; VETERINARY;

ANIMALS; AUSTRALIA; BACTERIAL CAPSULES; CATTLE; DNA, BACTERIAL; FEMALE; GENOTYPE; GENOTYPING TECHNIQUES; INDIA; MASTITIS, BOVINE; MICE; POLYSACCHARIDES, BACTERIAL; SPECIFIC PATHOGEN-FREE ORGANISMS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84937854326     PISSN: 00050423     EISSN: 17510813     Source Type: Journal    
DOI: 10.1111/avj.12349     Document Type: Article

References (56)

1. Dairy Australia. Dairy Australia Strategic Plan 2011-2015. http://www.dairyaustralia.com.au/Our-DairyIndustry/~/media/Publications/Strategic%20Plan/2011%20-%2015/Dairy%20Australias%20strategic%20plans%20for%202011%202015.ashx?la=en. Accessed October 2011.
2. Dua K. Incidence, aetiology and estimated loss due to mastitis in India: an update. Indian Dairyman 2001;53:41-48.
3. Workineh S, Bayleyegn H, Mekonnen H et al. Prevalence and aetiology of mastitis in cows from two major Ethiopian dairies. Trop Anim Health Prod 2002;34:19-25.
4. Barrett DJ, Healy AM, Leonard FC et al. Prevalence of pathogens causing subclinical mastitis in 15 dairy herds in the Republic of Ireland. Irish Vet J 2005;58:333-337.
5. Middleton JR. Staphylococcus aureus antigen and challenges in vaccine development. Expert Rev Vaccines 2008;7:805-818.
6. Unnerstad HA, Lindberg KP, Waller T et al. Microbial aetiology of acute clinical mastitis and agent-specific risk factors. Vet Microbiol 2009;137:90-97.
7. Pereira UP, Oliveira DG, Mesquita LR et al. Efficacy of Staphylococcus aureus vaccines for bovine mastitis: a systematic review. Vet Microbiol 2011;148:117-124.
8. Sharma N, Maiti SK. Incidence, etiology and antibiogram of sub clinical mastitis in cows in Durg, Chattisgarh. Indian J Vet Res 2010;19:45-54.
9. Mein GA. Review and recommendations on mastitis issues in the Victorian dairy industry. A review for the Gardiner Foundation. Melbourne, VIC, 2011;1-33.
10. Shi D, Hao Y, Zhang A et al. Antimicrobial resistance of Staphylococcus aureus isolated from bovine mastitis in China. Trans Emerg Dis 2010;57:221-224.
11. Holmes MA, Zadoks RN. Methicillin resistant Staphylococcus aureus in human and bovine mastitis. J Mammary Gland Biol Neoplasia 2011;16:373-382.
12. Park YK, Fox LK, Hancock DD et al. Prevalence and antibiotic resistance of mastitis pathogens isolated from dairy herds transitioning to organic management. Vet Sci 2012;13:103-105.
13. Haran KP, Godden SM, Boxrud D et al. Prevalence and characterization of Staphylococcus aureus, including methicillin resistant Staphylococcus aureus isolated from bulk tank milk from Minnesota dairy farms. J Clin Microbiol 2012;50:688-695.
14. Paterson GK, Harrison EM, Craven EF et al. Incidence and characterisation of methicillin resistant Staphylococcus aureus (MRSA) from nasal colonization in participants attending a cattle veterinary conference in the UK. PLoS One 2013. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0068463. Accessed May 2015.
15. Pu W, Su Y, Li J et al. High incidence of oxacillin-susceptible mecA positive Staphylococcus aureus (OS-MRSA) associated with bovine mastitis in China. PLoS One 2014. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0088134. Accessed May 2015.
16. Melchior MB, Vaarkamp H, Fink-Gremmels J. Biofilms: a role in recurrent mastitis infections? Vet J 2006;171:398-407.
17. Melchior MB, Fink-gremmels J, Gaastra W. Comparative assessment of the antimicrobial susceptibility of Staphylococcus aureus isolates from bovine mastitis in biofilm versus planktonic culture. J Vet Med B Infect Dis Vet Public Health 2006;53:326-332.
18. Babra C, Gogoi-Tiwari J, Pier G et al. The persistence of biofilm-associated antibiotic resistance of Staphylococcus aureus isolated from clinical bovine mastitis cases in Australia. Folia Microbial 2013;58:469-474.
19. Devriese LA. Coagulase-negative staphylococci in animals. In: Mardh PA, Schleifer KH, editors. Coagulase negative staphylococci. Alunguist and Wiksell, Stockholm, 1986:51-77.
20. Sol J, Sampimon OC, Barkema HW et al. Factors associated with cure after therapy of clinical mastitis caused by Staphylococcus aureus. J Dairy Sci 2000;83:278-284.
21. Gogoi-Tiwari J, Tiwari HK. Staphylococcal zoonosis on dairy farms in Assam and Meghalaya. Indian J Publ Health 2007;51:97-100.
22. Sakwinska O, Giddey M, Moreillon M et al. Staphylococcus aureus host range and human host shift. Appl Environ Microbiol 2011;77:5908-5915.
23. Fluit AC. Livestock-associated Staphylococcus aureus. Clin Microbiol Infect 2012;18:735-744.
24. Wilkinson BJ. Staphylococcal capsules and slime. In: Easmon C, Adlam C, editors. Staphylococci and staphylococcal infections. Academic Press, London, 1983:481-523.
25. Thakker M, Park JS, Carey V et al. Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteraemia model. Infect Immun 1998;66:5183-5189.
26. Verdier I, Durand G, Bes M et al. Identification of the capsular polysaccharides in Staphylococcus aureus clinical isolates by PCR and agglutination tests. J Clin Microbiol 2007;45:725-729.
27. O'Riordan K, Lee JC. Staphylococcus aureus capsular polysaccharides. Clin Microbiol Rev 2004;17:218-234.
28. Sompolinsky D, Samra Z, Karakawa WW et al. Encapsulation and capsular types in isolates of Staphylococcus aureus from different sources and relationship to phage types. J Clin Microbiol 1985;22:828-834.
29. Guidry A, Fattom A, Patel A. Serotyping scheme for Staphylococcus aureus isolated from cows with mastitis. Am J Vet Res 1998;59:1537-1539.
30. Cocchiaro JL, Gomez MI, Risley A et al. Molecular characterization of the capsule locus from non-typeable Staphylococcus aureus. Mol Microbiol 2006;59:948-960.
31. Poutrel B, Boutonnier A, Sutra L et al. Prevalence of capsular polysaccharide types 5 and 8 among Staphylococcus aureus isolates from cow, goat, and ewe milk. J Clin Microbiol 1988;26:38-40.
32. Fattom AR, Schneerson SS, Vann W et al. Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A. Infect Immun 1990;58:2367-2374.
33. Goldblatt D. Conjugate vaccines. Clin Exp Immunol 2000;119:1-3.
34. Ma J, Cocchiaro J, Lee JC. Evaluation of serotypes of Staphylococcus aureus strains used in the production of a bovine mastitis bacterin. J Dairy Sci 2004;87:178-182.
35. Arbeit RD, Karakawa WW, Vann WF et al. Predominance of two newly described capsular polysaccharides types among clinical isolates of Staphylococcus aureus. Diagn Microbiol Infect Dis 1984;2:85-91.
36. Hochkeppel HK, Brun DG, Vischer W et al. Serotyping and electron microscopy studies of Staphylococcus aureus clinical isolates with monoclonal antibodies to capsular polysaccharide type 5 and type 8. J Clin Microbiol 1987;25:526-30.
37. Han HR, Pak SI, Guidry A. Prevalence of capsular polysaccharide (CP) types of Staphylococcus aureus isolated from bovine mastitic milk and protection of Staphylococcus aureus infection in mice with CP vaccine. J Vet Med Sci 2000;62:1331-1333.
38. Roghmann M, Taylor KL, Gupte A et al. Epidemiology of capsular and surface polysaccharide in Staphylococcus aureus infections complicated by bacteraemia. Hosp Infect 2005;59:27-32.
39. Nanra JS, Buitrago SM, Crawford S et al. Capsular polysaccharides are an important immune evasion mechanism for Staphylococcus aureus. Hum Vaccin Immunother 2013;9:480-487.
40. Buchanan RE, Gibbons NE. Bergey's manual of determinative bacteriology. 8th edn. Williams & Wilkins, Baltimore, 1974.
41. Fournier JM, Bann WF, Karakawa WW. Purification and characterization of Staphylococcus aureus type 8 capsular polysaccharide. Infect Immun 1984;45:87-93.
42. Moore PCI, Lindsay JA. Genetic variation among hospital isolates of methicillin-sensitive Staphylococcus aureus: evidence for horizontal transfer of virulence genes. J Clin Microbiol 2001;39:2760-2767.
43. Karakawa WW, Vann WF. Capsular polysaccharides of Staphylococcus aureus. Semin Infect Dis 1982;4:285-293.
44. Lee JC, Liu MJ, Parsonnet J et al. Expression of type-8 capsular polysaccharide and production of toxic shock syndrome toxin-1 are associated among vaginal isolates of Staphylococcus aureus. J Clin Microbiol 1990;28:2612-2615.
45. Sordelli DO, Buzzola FR, Gomez MI et al. Capsule expression by bovine isolates of Staphylococcus aureus from Argentina: genetic and epidemiologic analyses. J Clin Microbiol 2000;38:846-850.
46. Tollersrud T, Kenny K, Caugant DA et al. Characterisation of isolates of Staphylococcus aureus from acute, chronic and subclinical mastitis in cows in Norway. Acta Pathol Microbiol Immunol Scand 2000;108:565-572.
47. Paul-Satyaseela M, van Belkum A, Shivannavar CT et al. Carriage of capsulated strains of Staphylococcus aureus: a population-based study performed in Gulbarga, South India. Epidemiol Infect 2004;132:831-838.
48. Schlichting L, Branger C, Fournier JM et al. Typing of Staphylococcus aureus by pulsed-field gel electrophoresis, zymotyping, capsular typing, and phage typing: Resolution of clonal relationships. J Clin Microbiol 1993;31:227-232.
49. Goud R, Gupta S, Neogi U et al. Community prevalence of methicillin and vancomycin resistant Staphylococcus aureus in and around Bangalore, southern India. Rev Soc Bras Med Trop 2011;44:309-312.
50. Shambat S, Nadig S, Prabhakara S et al. Clonal complexes and virulence factors of Staphylococcus aureus from several cities in India. BMC Microbiol 2012;12:64.
51. Upadhyay A, Kataria AK, Sharma R et al. Capsular typing of Staphylococcus aureus isolates from cattle and goat mastitis by PCR targeting cap5K and cap8K genes. Indian J Anim Sci 2010;80:1062-1065.
52. Camussone C, Rejf P, Pujato N et al. Genotypic and phenotypic detection of capsular polysaccharides in Staphylococcus aureus isolated from bovine intramammary infections in Argentina. Braz J Microbiol 2012;43:1010-1014.
53. Sutter DE, Summers AM, Keys CE et al. Capsule serotype of Staphylococcus aureus in the era of community-acquired MRSA. FEMS Immunol Med Microbiol 2011;63:16-24.
54. Poutrel B, Gilbert FB, Lebrun M. Effects of culture conditions on production of type 5 capsular polysaccharide by human and bovine Staphylococcus aureus strains. Clin Diagn Lab Immunol 1995;2:166-171.
55. Poutrel B, Rainard P, Sarradin P. Heterogeneity of cell associated CP5 expression on Staphylococcus aureus strains demonstrated by flow cytometry. Clin Diagn Lab Immunol 1997;4:275-278.
56. Gening ML, Maira-Litran T, Kropec A et al. Synthetic β-(1→6)-linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogens. Infect Immun 2010;78:764-772.